ASX - Delayed Quote AUD
Bio-Gene Technology Limited (BGT.AX)
0.0250
0.0000
(0.00%)
At close: 3:07:04 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-2,754.2450
-2,754.2450
-3,276.3540
-1,992.9560
-1,825.5220
Investing Cash Flow
-5.6980
-5.6980
--
-6.8400
-3.0290
Financing Cash Flow
1,978.9740
1,978.9740
-75
4,408.4820
239.8780
End Cash Position
2,209.5580
2,209.5580
2,990.5270
6,341.8810
3,933.1950
Interest Paid Supplemental Data
--
--
--
--
0.3370
Capital Expenditure
-5.6980
-5.6980
--
-6.8400
-3.0290
Issuance of Capital Stock
2,034.1330
2,034.1330
--
4,719.3100
272.6000
Repurchase of Capital Stock
-55.1590
-55.1590
--
-235.8280
-21.0590
Free Cash Flow
-2,759.9430
-2,759.9430
-3,276.3540
-1,999.7960
-1,828.5510
6/30/2021 - 11/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade